Helping Families Pilot of a Family Resilience Program for Families Experiencing Homelessness
NCT ID: NCT04273126
Last Updated: 2024-06-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
73 participants
INTERVENTIONAL
2020-02-19
2023-04-03
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
At this time, all assessments and intervention are being conducted remotely due to the pandemic.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Collaboration to Promote Early Childhood Well Being in Families Experiencing Homelessness
NCT03530137
Families Coping With Mental Illness Program
NCT00435721
Family Partner Navigation for Children
NCT03569449
Building Resilient Families
NCT05388864
Feasibility of a Positive Parenting Program for Women Experiencing Homelessness Who Have a History of Interpersonal Violence
NCT06246773
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention
This arm consists of approximately 8-10 modules lasting approximately one hour and consisting of psychoeducation and core components including communication, problem solving, goal setting, and dealing with stress, tailored to families with experiences of homelessness and parental substance use.
Adapted Family Resilience Intervention
The program consists of approximately 8-10 modules lasting approximately one hour. Sessions focus on psychoeducation and key resilience skills.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Adapted Family Resilience Intervention
The program consists of approximately 8-10 modules lasting approximately one hour. Sessions focus on psychoeducation and key resilience skills.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Family has a history of homelessness within the past two years (homelessness defined by the Department of Health and Human Services definition)
* Parent/guardian/caregiver has custody of and cares for a youth between the ages of 8-17
* Both youth and parent/guardian/caregiver are able to take part in an 8 module session intervention
* Has taken part in a Families OverComing Under Stress (FOCUS) intervention previously
8 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Drug Abuse (NIDA)
NIH
American Academy of Child Adolescent Psychiatry.
OTHER
University of California, Los Angeles
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Roya Ijadi-Maghsoodi, MD, MSHPM
Assistant Professor in Residence
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Roya Ijadi-Maghsoodi, MD, MSHPM
Role: PRINCIPAL_INVESTIGATOR
University of California, Los Angeles
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UCLA
Los Angeles, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.